An observational study in Castleman Disease, Unicentric Castleman Disease and Surgery, sponsored by Charles University, Czech Republic. Completed. Per ClinicalTrials.gov, last updated 2022-06-30.
Sponsored by Charles University, Czech Republic · Observational
Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.
33 studies on the registry are indexed under Castleman Disease; 10 are open to participants now.
This study's enrollment of 20 is below the median of 265 across 10 observational studies indexed under Castleman Disease.
Browse Castleman Disease studies →Charles University, Czech Republic is the lead sponsor of 220 studies on the registry; 76 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Group of patients with unicentric form of Castleman disease
Exclusion Criteria:
Evaluation of benefit according to surgery
5 year survival
surgery treatment success
Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression
recurence rate
surgery treatment success
Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charles University, Czech Republic